Our COO, Tanaka, and our business manager, Akane, Launched the IoMD working group at the Japan Digital Therapeutics Association

Our CSO, Hiroaki Kato, was interviewed by Vision and Strategy, August 20.

Our COO, Tanaka, was interviewed by Medical DX.

Our COO Tanaka participated in AI medical device development seminar

Our CEO, Sho Okiyama, participated in 21st Century Advanced Medical Consortium

Our COO Tanaka has been appointed as a health care expert.

Aillis funded by Mirai Creation Fund (backed by Toyota) and Cyberdyne.

Hiroshi Yoshihara won a gold medal in PANDA Challenge on Kaggle and became a Kaggle Master.

Our CSO, Hiroaki Kato, participated in an online event by Antaa.

Our CSO, Hiroaki Kato, was interviewed by Medical DX.

Our COO, Daichi Tanaka, contributed an article to Technical Information Institute: "Thinking Healthcare Business in the With-Corona Era".

news release: 06/18/2020

Aillis was selected as one of the [90+ Artificial Intelligence Startups In Healthcare] by CB Insights.

Aillis was introduced on NIKKEI MJ.

Our CEO, Sho Okiyama, participated in a panel discussion titled "Building an effective HealthTech CEO Covid-19 survival strategy" by Galen Growth.

Our CEO, Sho Okiyama, was interviewed by NIKKEI STYLE.

Our CSO, Hiroaki Kato, was interviewed by Japanese Cabinet Office National Strategic Special Zones.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer of the Graduate School of Tohoku University.

Our CSO, Hiroaki Kato, has been reappointed as Clinical Associate Professor of Tokyo Medical and Dental University.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer of Yokohama City University.